Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

BACKGROUND Contrast MRI enhancement patterns in several pathophysiologies resulting from ischemic myocardial injury are controversial or have not been investigated. We compared contrast enhancement in acute infarction (AI), after severe but reversible ischemic injury (RII), and in chronic infarction. METHODS AND RESULTS In dogs, a large coronary artery was occluded to study AI and/or chronic infarction (n = 18), and a second coronary artery was chronically instrumented with a reversible hydraulic occluder and Doppler flowmeter to study RII (n = 8). At 3 days after surgery, cine MRI revealed reduced wall thickening in AI (5+/-6% versus 33+/-6% in normal, P<0.001). In RII, wall thickening before, during, and after inflation of the occluder for 15 minutes was 35+/-5%, 1+/-8%, and 21+/-10% and Doppler flow was 19.8+/-5.3, 0.2+/-0.5, and 56.3+/-17.7 (peak hyperemia) cm/s, respectively, confirming occlusion, transient ischemia, and reperfusion. Gd-DTPA-enhanced MR images acquired 30 minutes after contrast revealed hyperenhancement of AI (294+/-96% of normal, P<0.001) but not of RII (98+/-6% of normal, P = NS). Eight weeks later, the chronically infarcted region again hyperenhanced (253+/-54% of normal, n = 8, P<0.001). High-resolution (0.5 x 0.5 x 0.5 mm) ex vivo MRI demonstrated that the spatial extent of hyperenhancement was the same as the spatial extent of myocyte necrosis with and without reperfusion at 1 day (R = 0.99, P<0.001) and 3 days (R = 0.99, P<0.001) and collagenous scar at 8 weeks (R = 0.97, P<0.001). CONCLUSIONS In the pathophysiologies investigated, contrast MRI distinguishes between reversible and irreversible ischemic injury independent of wall motion and infarct age.

[1]  R. Jennings,et al.  Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. , 1974, The American journal of pathology.

[2]  R. Jennings,et al.  The Changing Anatomic Reference Base of Evolving Myocardial Infarction: Underestimation of Myocardial Collateral Blood Flow and Overestimation of Experimental Anatomic Infarct Size Due to Tissue Edema, Hemorrhage and Acute Inflammation , 1979, Circulation.

[3]  F. Buonanno,et al.  Quantification of Experimental Myocardial Infarction Using Nuclear Magnetic Resonance Imaging and Paramagnetic Ion Contrast Enhancement in ExcisedCanine Hearts , 1982, Circulation.

[4]  R. Jennings,et al.  Comparison of the effect of ischaemia and anoxia on the sarcolemma of the dog heart. , 1983, European heart journal.

[5]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.

[6]  R. Ehman,et al.  Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. , 1984, Radiology.

[7]  R. Jennings,et al.  Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. , 1985, Circulation research.

[8]  R. Jennings,et al.  Effect of Reperfusion Late in the Phase of Reversible Ischemic Injury: Changes in Cell Volume, Electrolytes, Metabolites, and infrastructure , 1985, Circulation research.

[9]  D Revel,et al.  Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. , 1986, Radiology.

[10]  R W Parkey,et al.  Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. , 1986, The American journal of cardiology.

[11]  F. C. Dougherty,et al.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.

[12]  R. Peshock,et al.  Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. , 1986, Circulation.

[13]  R. Peshock,et al.  Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. , 1988, Journal of the American College of Cardiology.

[14]  T Nakatani,et al.  Determination of infarct size of acute myocardial infarction in dogs by magnetic resonance imaging and gadolinium-DTPA: comparison with indium-111 antimyosin imaging. , 1987, American journal of physiologic imaging.

[15]  N. Yamada,et al.  Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. , 1989, AJR. American journal of roentgenology.

[16]  P. V. van Dijkman,et al.  Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA--enhanced MR imaging. , 1989, Radiology.

[17]  P. V. van Dijkman,et al.  Diagnostic significance of gadolinium-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: its potential in assessing reperfusion. , 1990, British heart journal.

[18]  R. Edelman,et al.  First-pass cardiac perfusion: evaluation with ultrafast MR imaging. , 1990, Radiology.

[19]  M. Sprenger,et al.  Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. , 1990, The American journal of cardiology.

[20]  C B Higgins,et al.  Occlusive and reperfused myocardial infarcts: MR imaging differentiation with nonionic Gd-DTPA-BMA. , 1991, Radiology.

[21]  P. V. van Dijkman,et al.  Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. , 1991, Radiology.

[22]  C B Higgins,et al.  Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. , 1992, Radiology.

[23]  K. Uğurbil,et al.  Contrast‐enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia , 1993, Magnetic resonance in medicine.

[24]  B. Gersh,et al.  Thrombolysis and Myocardial Salvage Results of Clinical Trials and the Animal Paradigm‐ Paradoxic or Predictable? , 1993, Circulation.

[25]  Aeilko H. Zwinderman,et al.  Magnetic Resonance Imaging During Dobutamine Stress for Detection and Localization of Coronary Artery Disease: Quantitative Wall Motion Analysis Using a Modification of the Centerline Method , 1994, Circulation.

[26]  U. Sechtem,et al.  [Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality]. , 1994, Herz.

[27]  F. Fedele,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of magnetic resonance imaging. , 1994, American heart journal.

[28]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.

[29]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[30]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[31]  Katherine C. Wu,et al.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.

[32]  R O Bonow,et al.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.